Home/Filings/4/0001415889-24-012159
4//SEC Filing

Attar Eyal C. 4

Accession 0001415889-24-012159

CIK 0001817229other

Filed

May 2, 8:00 PM ET

Accepted

May 3, 4:15 PM ET

Size

4.9 KB

Accession

0001415889-24-012159

Insider Transaction Report

Form 4
Period: 2024-05-01
Attar Eyal C.
CHIEF MEDICAL OFFICER
Transactions
  • Tax Payment

    Common Stock

    2024-05-01$1.77/sh1,146$2,028111,707 total
Footnotes (1)
  • [F1]Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units.

Issuer

Vor Biopharma Inc.

CIK 0001817229

Entity typeother

Related Parties

1
  • filerCIK 0001789076

Filing Metadata

Form type
4
Filed
May 2, 8:00 PM ET
Accepted
May 3, 4:15 PM ET
Size
4.9 KB